Point-of-care diagnostics company Molbio Diagnostics Ltd, backed by Temasek and Motilal Oswal Private Equity, has fixed a price band of Rs 768-807 per share for its Initial Public Offering (IPO), which will open for subscription on August 10. The initial share sale, estimated at Rs 904 crore to Rs 940 crore at the lower and upper ends of the price band, respectively, will conclude on August 12.
